Episodes

Wednesday Feb 28, 2018
US Generic Drug Policy: Less Cost, Same Impact
Wednesday Feb 28, 2018
Wednesday Feb 28, 2018
Maryll Toufanian, JD, Acting Director, US FDA Office of Generic Drug Policy, discusses the US FDA’s Drug Competition Action Plan, why US consumers can feel safe taking generic drugs, and how generic drugs can help reduce costs for healthcare patients and systems. Learn more at our Complex Drug-Device Generic Combination Products conference.
Version: 20241125
No comments yet. Be the first to say something!